Nicholas Investment Partners, LP
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 1389574
RANCHO SANTA FE, CA
Position in NAMS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,005,603
-$3,481,135 QoQ
Shares Held
125,136
-41.4% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nicholas Investment Partners, LP holds $271,971,066 across 20 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
244,594 | $45,807,564 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
98,974 | $24,225,865 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
395,844 | $23,893,143 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
311,494 | $23,200,073 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
172,695 | $20,217,403 | |
| 6 | ELVN |
Enliven Therapeutics, Inc.
|
391,529 | $19,870,096 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
186,769 | $18,206,242 | |
| 8 | CYTK |
Cytokinetics Inc
|
209,071 | $17,810,758 |
All Filings in NAMS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,005,603 | 125,136 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,486,738 | 213,419 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,049,180 | 177,538 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,096,033 | 115,739 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||